Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine and Gamma Knife Radiosurgery for Recurrent Glioblastoma
NCT04205357Phase 1Completed
- Sponsor
- Haukeland University Hospital
- Start
- Mar 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 5-aminosalicylic acid + sulphasalazine in glioblastoma (GBM), sponsored by Haukeland University Hospital. Started Mar 2020; status: completed.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04205357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205357.